YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy.
Front Oncol. 2021 May 6;11:607224. doi: 10.3389/fonc.2021.607224. eCollection 2021.
Front Oncol. 2021.
PMID: 34026603
Free PMC article.